Evidence map›Paper›PMID 38222286›Full record

ReviewPhysiology and molecular biology of plants : an international journal of functional plant biology2023

3Bs of CRISPR-Cas mediated genome editing in plants: exploring the basics, bioinformatics and biosafety landscape.

Lalit Kharbikar, Rocktotpal Konwarh, Monoswi Chakraborty, Shweta Nandanwar, Ashish Marathe, Yogesh Yele, Probir Kumar Ghosh, Neeti Sanan-Mishra, Anand Pratap Singh

Open access · hybridAbstract readReview
In one paragraph

Review in Physiology and molecular biology of plants : an international journal of functional plant biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Lalit KharbikarICAR - National Institute of Biotic Stress Management (NIBSM), Raipur, India.ORCID 0000-0002-8250-3132
Rocktotpal KonwarhDepartment of Biotechnology, Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.
Monoswi ChakrabortyInstitute of Bioinformatics and Applied Biotechnology, Biotech Park, Bengaluru, Karnataka India.
Shweta NandanwarICAR - National Institute of Biotic Stress Management (NIBSM), Raipur, India.
Ashish MaratheICAR - National Institute of Biotic Stress Management (NIBSM), Raipur, India.
Yogesh YeleICAR - National Institute of Biotic Stress Management (NIBSM), Raipur, India.
Probir Kumar GhoshICAR - National Institute of Biotic Stress Management (NIBSM), Raipur, India.
Neeti Sanan-MishraInternational Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
Anand Pratap SinghBaba Kinaram Research Foundation (BKRF), Bramsthan, Mau, Uttar Pradesh India.
National Institute of Abiotic Stress Management · INInternational Centre for Genetic Engineering and Biotechnology · INSundaram Medical Foundation · INBiotech Park · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent thrust in research has projected the type II clustered regularly interspaced short palindromic repeats and associated protein 9 (CRISPR-Cas9) system as an avant-garde plant genome editing tool. It facilitates the induction of site-specific double-stranded DNA cleavage by the RNA-guided DNA endonuclease (RGEN), Cas9. Elimination, addition, or alteration of sections in DNA sequence besides the creation of a knockout genotype (CRISPRko) is aided by the CRISPR-Cas9 system in its wild form (wtCas9). The inactivation of the nuclease domain generates a dead Cas9 (dCas9), which is capable of targeting genomic DNA without scissoring it. The dCas9 system can be engineered by fusing it with different effectors to facilitate transcriptional activation (CRISPRa) and transcriptional interference (CRISPRi). CRISPR-Cas thus holds tremendous prospects as a genome-manipulating stratagem for a wide gamut of crops. In this article, we present a brief on the fundamentals and the general workflow of the CRISPR-Cas system followed by an overview of the prospects of bioinformatics in propelling CRISPR-Cas research with a special thrust on the available databases and algorithms/web-accessible applications that have aided in increasing the usage and efficiency of editing. The article also provides an update on the current regulatory landscape in different countries on the CRISPR-Cas edited plants to emphasize the far-reaching impact of the genomic editing technology. Supplementary Information: The online version contains supplementary material available at 10.1007/s12298-023-01397-3.

Indexed as

BiosafetyClimate-smart cropsCRISPR-Cas9CRISPR editCrop improvementdCas9DNA cleavageRegulatory policyRNA-guided DNA-endonuclease

Identifiers

PMID38222286
PMCPMC10784264
OpenAlexW4389450928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.